Inventor · disambiguated record
M. Patricia Beckmann
Also filed as: BECKMANN M P · BECKMANN M PATRICIA
36 granted patents·6 pending applications·2,211 citations·filing 1990–2009
99Inventor score
Top patents by PatentIndex Score
42 records- 0198US6716587B2Antibodies to interleukin-4 receptors and uses thereofIMMUNEX CORP·Filed 2002·Granted Apr 6, 2004·93 cites·8 claims
- 0298US6572852B2Method for suppressing inflammatory responses by administering TNFRIMMUNEX CORP·Filed 2001·Granted Jun 3, 2003·83 cites·8 claims
- 0398US5728813AAntibodies directed against elk ligandIMMUNEX CORP·Filed 1996·Granted Mar 17, 1998·165 cites·4 claims
- 0497US5969110AAntibodies that bind hek ligandsIMMUNEX CORP·Filed 1998·Granted Oct 19, 1999·154 cites·23 claims
- 0597US5843423AMethods of stimulating hematopoietic cells with flt3-ligandIMMUNEX CORP·Filed 1997·Granted Dec 1, 1998·95 cites·17 claims
- 0697US5599905AInterleukin-4 receptorsIMMUNEX CORP·Filed 1993·Granted Feb 4, 1997·143 cites·21 claims
- 0797US5395760ADNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1990·Granted Mar 7, 1995·259 cites·20 claims
- 0896US7317090B2Antibodies to Interleukin-4 receptors and uses thereofIMMUNEX CORP·Filed 2003·Granted Jan 8, 2008·59 cites·1 claims
- 0996US5717072AAntibodies that are immunoreactive with interleukin-4 receptorsIMMUNEX CORP·Filed 1995·Granted Feb 10, 1998·119 cites·6 claims
- 1095US5856296ADNA encoding interleukin-4 receptorsIMMUNEX CORP·Filed 1995·Granted Jan 5, 1999·107 cites·12 claims
- 1195US5712155ADNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1994·Granted Jan 27, 1998·90 cites·17 claims
- 1294US6548655B1Interleukin-4 receptorsIMMUNEX CORP·Filed 2000·Granted Apr 15, 2003·37 cites·46 claims
- 1394US6201105B1Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)Filed 1999·Granted Mar 13, 2001·77 cites·4 claims
- 1492USRE36755EDNA encoding tumor necrosis factor-α and -β receptorsIMMUNEX CORP·Filed 1998·Granted Jun 27, 2000·94 cites·1 claims
- 1592US5767065AUse of interleukin-4 receptors to inhibit biological responses mediated by interleukin-4IMMUNEX CORP·Filed 1995·Granted Jun 16, 1998·55 cites·21 claims
- 1690US7045128B2Antibodies against flt3-ligandIMMUNEX CORP·Filed 2002·Granted May 16, 2006·20 cites·15 claims
- 1790US6391581B1DNA encoding interleukin-4 receptorsIMMUNEX CORP·Filed 1998·Granted May 21, 2002·40 cites·69 claims
- 1890US5573924ACD27 ligandIMMUNEX CORP·Filed 1993·Granted Nov 12, 1996·82 cites·12 claims
- 1990US5554512ALigands for flt3 receptorsIMMUNEX CORP·Filed 1994·Granted Sep 10, 1996·89 cites·21 claims
- 2087US5670625AElk ligand fusion proteinsIMMUNEX CORP·Filed 1995·Granted Sep 23, 1997·35 cites·12 claims
- 2185US7057022B2Antibodies which specifically bind to TNF-RIMMUNEX CORP·Filed 2003·Granted Jun 6, 2006·13 cites·16 claims
- 2285US5516658ADNA encoding cytokines that bind the cell surface receptor hekIMMUNEX CORP·Filed 1994·Granted May 14, 1996·39 cites·27 claims
- 2385US5512457ACytokine designated elk ligandIMMUNEX CORP·Filed 1994·Granted Apr 30, 1996·48 cites·13 claims
- 2483US7459528B2Glycoproteins which bind to TNFIMMUNEX CORP·Filed 2005·Granted Dec 2, 2008·3 cites·30 claims
- 2583US5840869ADNA encoding interleukin-4 receptorsIMMUNEX CORP·Filed 1990·Granted Nov 24, 1998·39 cites·12 claims
- 2682US5738844ACytokines that bind the cell surface receptor hekIMMUNEX CORP·Filed 1995·Granted Apr 14, 1998·26 cites·24 claims
- 2781US6190655B1Methods of using Flt-3 ligand for exogenous gene transferIMMUNEX CORP·Filed 1998·Granted Feb 20, 2001·36 cites·24 claims
- 2881US5627267ACytokine designated elk ligandIMMUNEX CORP·Filed 1995·Granted May 6, 1997·23 cites·10 claims
- 2980US5945397APurified p75 (type II) tumor necrosis factor receptor polypeptidesIMMUNEX CORP·Filed 1996·Granted Aug 31, 1999·52 cites·52 claims
- 3076US6949366B2Cytokines that bind the cell surface receptor hekIMMUNEX CORP·Filed 2001·Granted Sep 27, 2005·5 cites·12 claims
- 3175US5284755ADNA encoding leukemia inhibitory factor receptorsIMMUNEX CORP·Filed 1992·Granted Feb 8, 1994·23 cites·16 claims
- 3266US2011053863A1Methods of using flt3-ligand in the treatment of cancerCELLDEX THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 3366US2007207164A1Methods of using flt3-ligand in the treatment of cancerIMMUNEX CORP·Filed 2006·Application pending·0 cites
- 3465US2004022767A1Novel cytokine designated elk ligandFiled 2003·Application pending·0 cites
- 3561US2009226472A1Interleukin-4 receptorsMOSLEY BRUCE A·Filed 2007·Application pending·0 cites
- 3660US2009270592A1Purified TNFR preparationsIMMUNEX CORP·Filed 2007·Application pending·0 cites
- 3758US7041282B2Ligands for flt3 receptorsIMMUNEX CORP·Filed 2001·Granted May 9, 2006·0 cites·10 claims
- 3857US7294331B2Methods of using flt3-ligand in hematopoietic cell transplantationIMMUNEX CORP·Filed 2002·Granted Nov 13, 2007·1 cites·60 claims
- 3953US6274117B1Cytokines that bind the cell surface receptor HekIMMUNEX CORP·Filed 1999·Granted Aug 14, 2001·6 cites·7 claims
- 4051US2005058622A1Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimensFiled 2003·Application pending·0 cites
- 4137US6919206B2Medium containing flt3 ligand for culturing hematophoietic cellsIMMUNEX CORP·Filed 1997·Granted Jul 19, 2005·1 cites·16 claims
- 4232US6540992B1Methods for using elk-L to enhance neuronal survivalGENENTECH INC·Filed 1998·Granted Apr 1, 2003·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when M. Patricia Beckmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →